Recent Quarter Total Invested
$6.57 M
Recent Quarter Institutional Ownership Percentage
7.69%
Total Invested of Last Quarter
$11.90 M
Ownership Percentage of Last Quarter
13.99%
Protalix BioTherapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 811,160 | $949,057 | 7,637.12% | 1.11% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 804,600 | $941,382 | -2.44% | 1.10% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 461,958 | $540,491 | 399.82% | 0.63% |
NORTHERN TRUST CORP | 08/14/2024 | 423,213 | $495,159 | -7.62% | 0.58% |
GSA CAPITAL PARTNERS LLP | 08/15/2024 | 401,244 | $469,000 | -18.71% | 0.55% |
BLACKROCK INC. | 08/13/2024 | 333,171 | $389,810 | -89.94% | 0.46% |
JANE STREET GROUP, LLC | 08/15/2024 | 290,259 | $339,603 | 903.63% | 0.40% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 183,790 | $215,034 | 0.00% | 0.25% |
Y-INTERCEPT (HONG KONG) LTD | 08/14/2024 | 158,259 | $185,163 | 100.00% | 0.22% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 158,247 | $185,149 | 107.90% | 0.22% |
SQUAREPOINT OPS LLC | 08/14/2024 | 137,764 | $161,184 | 673.30% | 0.19% |
CENTIVA CAPITAL, LP | 08/14/2024 | 130,332 | $152,488 | 100.00% | 0.18% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 121,030 | $141,605 | 100.00% | 0.17% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 111,164 | $130,062 | -2.96% | 0.15% |
MORGAN STANLEY | 10/17/2024 | 87,144 | $101,958 | -49.65% | 0.12% |
HRT FINANCIAL LP | 08/12/2024 | 80,224 | $93,000 | 100.00% | 0.11% |
PALOMA PARTNERS MANAGEMENT CO | 08/14/2024 | 79,442 | $92,947 | 100.00% | 0.11% |
ORIN GREEN FINANCIAL, LLC | 07/31/2024 | 72,000 | $84,240 | 0.00% | 0.10% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 09/16/2024 | 68,163 | $79,751 | 100.00% | 0.09% |
GROUND SWELL CAPITAL, LLC | 08/07/2024 | 62,234 | $72,814 | 100.00% | 0.09% |
AQR CAPITAL MANAGEMENT LLC | 08/14/2024 | 57,106 | $66,814 | 100.00% | 0.08% |
CITADEL ADVISORS LLC | 08/14/2024 | 55,100 | $64,467 | 330.47% | 0.08% |
TWO SIGMA SECURITIES, LLC | 08/14/2024 | 52,320 | $61,214 | -38.67% | 0.07% |
COMMONWEALTH EQUITY SERVICES, LLC | 07/31/2024 | 50,100 | $59,000 | 0.00% | 0.07% |
HSBC HOLDINGS PLC | 08/12/2024 | 47,624 | $58,101 | 2.02% | 0.07% |
BARCLAYS PLC | 08/14/2024 | 35,427 | $41,000 | -57.02% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2024 | 34,167 | $39,975 | 100.00% | 0.05% |
FRANKLIN RESOURCES INC | 08/14/2024 | 33,892 | $39,654 | 1.03% | 0.05% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 09/16/2024 | 32,031 | $37,476 | 100.00% | 0.04% |
MIRABELLA FINANCIAL SERVICES LLP | 08/08/2024 | 30,000 | $35,100 | 100.00% | 0.04% |
SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 27,900 | $32,643 | 100.00% | 0.04% |
CAPITAL PERFORMANCE ADVISORS LLP | 08/02/2024 | 26,793 | $31,348 | 2.04% | 0.04% |
APTUS CAPITAL ADVISORS, LLC | 07/31/2024 | 20,925 | $24,482 | 6.65% | 0.03% |
ETHIC INC. | 08/13/2024 | 20,039 | $23,446 | 100.00% | 0.03% |
CITADEL ADVISORS LLC | 08/14/2024 | 18,468 | $21,608 | -51.13% | 0.03% |
TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 17,879 | $20,918 | 359.26% | 0.02% |
RHUMBLINE ADVISERS | 08/01/2024 | 17,666 | $20,668 | -76.89% | 0.02% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 17,400 | $20,358 | -37.41% | 0.02% |
KESTRA ADVISORY SERVICES, LLC | 08/14/2024 | 16,000 | $18,720 | 0.00% | 0.02% |
LIDO ADVISORS, LLC | 08/15/2024 | 15,554 | $18,198 | 0.00% | 0.02% |
JUMP FINANCIAL, LLC | 11/14/2024 | 14,224 | $16,642 | 100.00% | 0.02% |
BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 13,299 | $15,560 | 100.00% | 0.02% |
ALTSHULER SHAHAM LTD | 08/14/2024 | 12,142 | $14,206 | 0.00% | 0.02% |
SAVANT CAPITAL, LLC | 08/05/2024 | 11,996 | $14,036 | 100.00% | 0.02% |
CASCADE FINANCIAL PARTNERS, LLC | 07/31/2024 | 11,100 | $12,987 | 100.00% | 0.02% |
ELLEVEST, INC. | 08/14/2024 | 10,494 | $12,278 | 100.00% | 0.01% |
HARBOUR INVESTMENT MANAGEMENT LLC | 07/23/2024 | 10,100 | $11,817 | 0.00% | 0.01% |
FMR LLC | 08/13/2024 | 6,791 | $7,945 | 168.84% | 0.01% |
NATIONAL BANK OF CANADA /FI/ | 08/02/2024 | 6,100 | $6,954 | 0.00% | 0.01% |
TD WATERHOUSE CANADA INC. | 11/12/2024 | 6,000 | $6,840 | 0.00% | 0.01% |
Protalix BioTherapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of PLX shares?
During the previous two years, 70 institutional investors and hedge funds held shares of Protalix BioTherapeutics, Inc.. The most heavily invested institutionals were:
RENAISSANCE TECHNOLOGIES LLC: 955,900
GSA CAPITAL PARTNERS LLP: 435,213
MILLENNIUM MANAGEMENT LLC: 373,757
Stratos Wealth Partners, LTD.: 270,000
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 183,790
BlackRock Funding, Inc. /DE: 178,784
-
What percentage of Protalix BioTherapeutics, Inc. stock is owned by institutional investors?
7.69% of Protalix BioTherapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at PLX ?
Institutional investors have bought a total of 3.57 M shares in the last 24 months. This purchase volume represents approximately $6.03 M in transactions.